Last updated: 2026-09-16 13:20:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Artivion, Inc. (AORT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $25.78, with a market capitalisation of $1.22B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $19.16 to $48.25. This page covers its latest market performance, valuation, price trends and company information.
$1.22B | |
$25.39 | |
$48.25 | |
$9.64 | |
$25.38 | |
2.61K | |
713.90K | |
-- | |
$48.25 | |
$19.16 | |
-- | |
-- |
Artivion, Inc. (AORT) is trading at $25.78 in pre-market trading as of 2026-09-16 13:19:00, up 1.59% ($0.40) from the previous close of $25.38
Pre-market trading shows how investors are pricing AORT before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Artivion, Inc. (AORT) moved from $25.57 to $25.78, representing a gain of 0.84% ($0.21).
The stock traded between $24.40 and $26.21 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 626.00 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 22.8%
AORT is currently trading at $25.78, placing it 22.8% of the way from its 52-week low of $19.16 to its 52-week high of $48.25. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 1800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Artivion, Inc. (AORT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.